Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Januvia 25mg Tablets | 105-Count | SITAGLIPTIN
PharmaWeight Loss & Metabolic

Januvia 25mg Tablets | 105-Count | SITAGLIPTIN

$160

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse SITAGLIPTIN — 25mg per tablet, 105-count pack. DPP-4 inhibitor for type 2 diabetes — lowers blood glucose without hypoglycemia or weight gain. Well tolerated, suitable for elderly patients. Key warning: Dose reduction in renal impairment (eGFR under 45). Discontinue if pancreatitis suspected. Severe joint pain may be delayed onset. Heart failure hospitalization signal exists for DPP-4 inhibitor class.

SKU
VES-001128-JANUVIA-25MG-105TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Januvia 25mg (SITAGLIPTIN)?

DPP-4 inhibitor for type 2 diabetes — lowers blood glucose without hypoglycemia or weight gain. Well tolerated, suitable for elderly patients.

How it Works

Inhibits dipeptidyl peptidase-4, preventing degradation of incretin hormones GLP-1 and GIP — increases insulin secretion and decreases glucagon in a glucose-dependent manner.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
SITAGLIPTIN
Dose per Tablet
25MG
Pack Size
105 tablets
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Upper respiratory infection, nasopharyngitis, headache. Rare: pancreatitis, severe joint pain, bullous pemphigoid.

Safety Warnings

Dose reduction in renal impairment (eGFR under 45). Discontinue if pancreatitis suspected. Severe joint pain may be delayed onset. Heart failure hospitalization signal exists for DPP-4 inhibitor class. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.